Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03867396 · ClinicalTrials.gov registry record · NA
Evaluation of Speech-in-noise Performance in Cochlear Implant Recipients With a CROS Device on the Contralateral Ear
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03867396 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 40 participants.
The verdict
NCT03867396, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Speech understanding in noise remains the greatest challenge for people using cochlear implants, particularly when the speech of interest comes from the side of the head opposite to the implant. Recent findings in hearing technology allow for people to either use a hearing aid or a Contralateral Routing of Signal (CROS) device on the non-implanted ear. Differences in speech understanding may result depending on the device chosen by a person, and these differences may be measureable through speech discrimination measurement methods. This study intends to determine whether or not a CROS device improves speech perception in noise when the source of the speech of interest originates from the side of the head opposite to the implant.
Interventions
- DEVICE Hearing Aid
- DEVICE CROS
- OTHER Cochlear Implant Alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-01-23 |
| Est. Completion | 2021-02-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03867396
The ClinicalTrials.gov registry entry for NCT03867396 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Hearing Aid is the first listed.
NCT03867396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03867396 about?
NCT03867396 is a clinical study titled "Evaluation of Speech-in-noise Performance in Cochlear Implant Recipients With a CROS Device on the Contralateral Ear". Speech understanding in noise remains the greatest challenge for people using cochlear implants, particularly when the speech of interest comes from the side of the head opposite to the implant. Recent findings in hearing technology allow for people to either use a hearing aid or a Contralateral Rou...
What is the current status of trial NCT03867396?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-01-23. Estimated completion is 2021-02-11.
What interventions are being tested in trial NCT03867396?
The interventions under investigation include: Hearing Aid (DEVICE), CROS (DEVICE), Cochlear Implant Alone (OTHER).
Who is sponsoring clinical trial NCT03867396?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.